Skip to content
TrialScanner

NCT03782415

Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma

Phase 1/Phase 2CompletedMNOVLead

Registry record

Lead sponsor
MediciNova
Conditions
Glioblastoma; Recurrent Glioblastoma; GBM; Newly Diagnosed Glioblastoma
Primary completion
Aug 7, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03782415 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03782415: Study to Evaluate Ibudilast... | TrialScanner